- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Priority Health, Arine Partner to Optimize Medication Management
Priority Health has chosen Arine, the medication intelligence company, as its partner in a value-based care endeavor that strives to optimize members' health outcomes.
Grand Rapids, Michigan — Wanting to identify the top medication management program for its members—encompassing medication therapy, reduced costs, and improved health outcomes—Priority Health in November chose Arine, the medication intelligence company, as its partner in this value-based care endeavor.
Arine’s artificial intelligence (AI) capabilities will enable the nonprofit health plan to continue providing optimal care to its members while also striving for top quality ratings for several CMS’ Part C and D Star measures. In particular, Arine’s AI has the ability to pinpoint safe and effective, individualized, medication regimens by examining clinical, socioeconomic, and behavioral data.
“Priority Health is committed to improving health outcomes for our members and reducing costs,” said Christina Barrington, vice president of pharmacy programs at Priority Health. “Through this partnership, our members will continue receiving the care they need, lower their prescription costs and receive personalized medication advice.”
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Addressing the Bidirectional Impact of Schizophrenia and Substance Use Disorders
February 8th 2025Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, discusses the bidirectional relationship between schizophrenia and substance use disorders in an interview.
Read More
